‘You can’t rush science’ — Merck CEO stresses need for careful approach to coronavirus vaccine

- CNBC - Sep 9, 2020 -

Kevin Stankiewicz



  • “I know there are a lot of public voices talking about when vaccines will be ready, but the fact of the matter is you can’t rush science,” Merck CEO Kenneth Frazier told CNBC on Wednesday.

  • Frazier’s Merck was among the nine companies that signed a pledge to prioritize safety as the drugmakers seek regulatory approval.

  • “When you’re putting these vaccines into healthy people, you have to do everything possible to ensure that these vaccines are both safe and effective,” Frazier said on “Fast Money: Halftime Report.”


Merck CEO Kenneth Frazier on Wednesday emphasized the need for patience and strict adherence to scientific principles in the global push to develop a vaccine to prevent the coronavirus.


“I know there are a lot of public voices talking about when vaccines will be ready, but the fact of the matter is you can’t rush science,” Frazier said on CNBC’s “Fast Money: Halftime Report.”


Frazier’s comments come one day after Merck and other leading vaccine developers, from both the U.S. and the U.K., issued a pledge to make safety the top priority as they seek regulatory approval. And later Tuesday, AstraZeneca, another signatory of the letter, said it was putting its late-stage vaccine trial on hold due to safety concerns, with one participant in the U.K. having a possible serious adverse reaction. The company called it a “routine action” that “has to happen whenever there is a potentially unexplained illness in one of the trials.”


CONTINUAR LENDO:

https://www.cnbc.com/2020/09/09/merck-ken-frazier-you-cant-rush-science-for-coronavirus-vaccine.html?__source=sharebar|email&par=sharebar

© Todos os Direitos Reservados - heitordepaola.online

  • Facebook
  • Twitter
  • YouTube